These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11243987)

  • 1. One-year continuous inhaled nitric oxide for primary pulmonary hypertension.
    Pérez-Peñate G; Julià-Serdà G; Pulido-Duque JM; Górriz-Gómez E; Cabrera-Navarro P
    Chest; 2001 Mar; 119(3):970-3. PubMed ID: 11243987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unsuccessful treatment of pulmonary hypertension by inhaled nitric oxide and aerosolized prostacyclin.
    Tibballs J; Goh TH; McKenzie I; Hochmann M
    Anaesth Intensive Care; 1999 Jun; 27(3):316-7. PubMed ID: 10389572
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term inhalation of nitric oxide for a patient with primary pulmonary hypertension.
    Koh E; Niimura J; Nakamura T; Yamakage H; Takahashi H
    Jpn Circ J; 1998 Dec; 62(12):940-2. PubMed ID: 9890209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension.
    Robinson JN; Banerjee R; Landzberg MJ; Thiet MP
    Am J Obstet Gynecol; 1999 Apr; 180(4):1045-6. PubMed ID: 10203683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vardenafil and weaning from inhaled nitric oxide: effect on pulmonary hypertension in ARDS.
    Giacomini M; Borotto E; Bosotti L; Denkewitz T; Reali-Forster C; Carlucci P; Centanni S; Mantero A; Iapichino G
    Anaesth Intensive Care; 2007 Feb; 35(1):91-3. PubMed ID: 17323673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled nitric oxide for primary pulmonary hypertension in pregnancy.
    Lam GK; Stafford RE; Thorp J; Moise KJ; Cairns BA
    Obstet Gynecol; 2001 Nov; 98(5 Pt 2):895-8. PubMed ID: 11704193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up.
    Clark RH; Huckaby JL; Kueser TJ; Walker MW; Southgate WM; Perez JA; Roy BJ; Keszler M;
    J Perinatol; 2003 Jun; 23(4):300-3. PubMed ID: 12774137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with inhaled nitric oxide and intravenous vasodilators during acute and chronic experimental pulmonary hypertension.
    Aranda M; Bradford KK; Pearl RG
    Anesth Analg; 1999 Jul; 89(1):152-8. PubMed ID: 10389795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
    Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
    Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of inhaled nitric oxide in newborn medicine.
    Golombek SG
    Heart Dis; 2000; 2(5):342-7. PubMed ID: 11728280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis.
    Atz AM; Adatia I; Jonas RA; Wessel DL
    Am J Cardiol; 1996 Feb; 77(4):316-9. PubMed ID: 8607419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
    Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia.
    Kinsella JP; Parker TA; Ivy DD; Abman SH
    J Pediatr; 2003 Apr; 142(4):397-401. PubMed ID: 12712057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn.
    Davidson D; Barefield ES; Kattwinkel J; Dudell G; Damask M; Straube R; Rhines J; Chang CT
    Pediatrics; 1999 Aug; 104(2 Pt 1):231-6. PubMed ID: 10429000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential.
    Ichinose F; Roberts JD; Zapol WM
    Circulation; 2004 Jun; 109(25):3106-11. PubMed ID: 15226227
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide.
    Kelly LK; Porta NF; Goodman DM; Carroll CL; Steinhorn RH
    J Pediatr; 2002 Dec; 141(6):830-2. PubMed ID: 12461501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Inhaled Nitric Oxide Versus Inhaled Epoprostenol for Acute Pulmonary Hypertension Following Cardiac Surgery.
    McGinn K; Reichert M
    Ann Pharmacother; 2016 Jan; 50(1):22-6. PubMed ID: 26438636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effect of oral prostacyclin and inhaled nitric oxide on pulmonary hypertension in children.
    Ichida F; Uese K; Hashimoto I; Hamamichi Y; Tsubata S; Fukahara K; Murakami A; Miyawaki T
    J Cardiol; 1997 Apr; 29(4):217-24. PubMed ID: 9127838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.